Dan Călugăru1, Mihai Călugăru2. 1. Department of Ophthalmology, University of Medicine Cluj-Napoca, Romania. 2. OcuCenter Ophthalmological Clinic, Cluj-Napoca, Romania.
Abstract
PURPOSE: To report the case of a 48-year-old man with unilateral central retinal vein occlusion. METHODS: The clinical, hematologic and hypercoagulability evaluations of the patient were thoroughly and specifically carried out. RESULTS: The central retinal vein occlusion was of nonischemic type and was associated with polyglobulia, hyperleukocytosis, hypercholesterolemia, multiple dental foci, and pulmonary sequelae of tuberculosis. CONCLUSIONS: When a patient less than 50 years of age experiences central retinal vein occlusion, other mechanisms, such as the hyperviscosity syndrome or the inflammatory condition (inflammation of the central retinal vein) should be specifically considered and accounted for.
PURPOSE: To report the case of a 48-year-old man with unilateral central retinal vein occlusion. METHODS: The clinical, hematologic and hypercoagulability evaluations of the patient were thoroughly and specifically carried out. RESULTS: The central retinal vein occlusion was of nonischemic type and was associated with polyglobulia, hyperleukocytosis, hypercholesterolemia, multiple dental foci, and pulmonary sequelae of tuberculosis. CONCLUSIONS: When a patient less than 50 years of age experiences central retinal vein occlusion, other mechanisms, such as the hyperviscosity syndrome or the inflammatory condition (inflammation of the central retinal vein) should be specifically considered and accounted for.
Entities:
Keywords:
central retinal vein occlusion; focal phlebitis; hyperviscosity syndrome; intravitreal bevacizumab; young adult
Authors: Ian L McAllister; Mark E Gillies; Lynne A Smithies; Elena Rochtchina; Colin A Harper; Mark D Daniell; Ian J Constable; Paul Mitchell Journal: Ophthalmology Date: 2010-02-16 Impact factor: 12.079